PyriferoneAlternative Names: BIM 15427
Latest Information Update: 14 Nov 1994
At a glance
- Originator Biomeasure Inc
- Class Antibacterials; Antivirals; Small molecules
- Mechanism of Action Natural killer cell stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer; Viral hepatitis
Most Recent Events
- 14 Nov 1994 Discontinued-Preclinical for Viral hepatitis in USA (Unknown route)